TABLE 3.
Current regenerative medicine therapy (RMT) in clinical trials.
| Current RMT Clinical Trials | Treatment | Update on the Clinical Trial | References (s) |
|---|---|---|---|
| Precision medicine | Treating cancer through a tumor profiling approach that can identify various anti-cancer-therapies | No data mentioned | (Malone et al., 2020; Lightner and Chan, 2021) |
| Unmatched donor umbilical cord-derived mesenchymal stem cells | Knee articular cartilage defects | Not yet recruiting | (Wu et al., 2019) |
| Bone marrow, hematopoietic stem cell (HSC) transplants | Blood diseases and cancer | No data mentioned | Khaddour et al. (2021) |
| Cellular therapy | Ankle sprain | No data mentioned | Loo and Wong, (2021) |
| Autologous peripheral blood stem cell | Articular cartilage regeneration | Completed | Saw et al. (2013) |
| Mesenchymal Stem Cell | Anti-aging | Phase 1 (Not recruiting) | Zarei and Abbaszadeh, (2019) |
| Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System | Single Coronary Vessel disease | Recruiting | Zheng et al. (2019) |